QIAGEN today announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a leading provider of scalable, instrument-free solutions for single-cell research. The ...
QIAGEN N.V. today announced results for the third quarter of 2025 and reaffirmed its outlook for solid profitable growth while raising its profitability targets. QIAGEN reaffirmed its FY 2025 outlook ...
IEEE Spectrum on MSN
Inside the Massive Effort to Sequence All of Europe’s Lepidoptera
It’s a little after 6:30 on a brisk July morning in a stone hut high in the Italian Alps. A gently hissing wood fire is ...
Working with the same tumor slices that pathologists use to diagnose and guide treatment of patients, however, Carstens can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback